Molecular dosimetry of 1,2,3,4-diepoxybutane - Lnduced DNA-DNA cross-links in B6C3F1 mice and F344 rats exposed to 1,3-butadiene by inhalation

Cancer Research

Volumn 69, Issue 6, 2009, Pages 2479-2486

  Goggin, Melissa ^a   Swenberg, James A ^b   Walker, Vernon E ^c,d   Tretyakova, Natalia ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^d BioMosaics Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; BUTADIENE DIEPOXIDE; CARCINOGEN; 1,3 BUTADIENE DERIVATIVE; 1,3-BUTADIENE; DNA; EPOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CANCER INCIDENCE; CARCINOGENESIS; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; DNA CROSS LINKING; DOSE RESPONSE; DOSIMETRY; FEMALE; GENOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LIVER; LUNG; MALE; METABOLISM; MOUSE; MUTAGENIC ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SPECIES DIFFERENCE; TANDEM MASS SPECTROMETRY; THYMUS; ANIMAL; DNA ADDUCT; DRUG EFFECT; EXPOSURE; FISCHER 344 RAT; METHODOLOGY;

ANIMALS; BUTADIENES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; DNA ADDUCTS; EPOXY COMPOUNDS; FEMALE; INHALATION EXPOSURE; MALE; MICE; RATS; RATS, INBRED F344; SEX FACTORS; TANDEM MASS SPECTROMETRY;

EID: 65549093299     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4152     Document Type: Article

References (45)

1. White WC. Butadiene production process overview. Chem Biol Interact 2007;166:10-4.
2. Pelz N, Dempster KM, Shore PR. Analysis of low molecular weight hydrocarbons including 1,3-butadiene in engine exhaust, gases using an aluminum oxide porous-layer open-tubular fused-silica column. J Chro- matogr Sci 1990;28:230-5.
3. Hecht SS. Tobacco smoke carcinogens and lung cancer.] Natl Cancer Inst 1999;91:1194-210.
4. Stayner LT, DankoviecDA, Smith RJ, Gilbert SJ, Bailer Aj. Human cancer risk and exposure to 1,3-butadiene-a tale of mice and men. Scand j Work Environ Health 2000;26:322-30.
5. Ward JB, Jr., Ammenheuser MM, Bechtold WE, Whorton EB, Jr., Legator MS. HPRT mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant. Environ Health Perspect 1994;102 Suppl 9:79-85.
6. Melnick RL, Huff J, Chou BJ, Miller RA. Carcinogenicity of l,3-butadiene in C57BL/6 x C3H El mice at low exposure concentrations. Cancer Res 1990;50:6592-9.
7. Melnick RL, Shackelford CC, Huff J. Carcinogenicity of 1,3-butadiene. Environ Health Perspect 1993;100:227-36.
8. Melnick RL, Huff JE. 1,3-Butadiene induces cancer in experimental animals at all concentrations from 6.25 to 8000 parts per million. JARC Sci Publ 1993;:309-22.
9. Malvoisin E, Roberfroid M. Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica 1982;12: 137-44.
10. Himmelstein MW, Turner Mj, Asgharian B, Bond JA. Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice. Toxicology 1996;113:306-09.
11. Krause RJ, Elfarra AA. Oxidation of butadiene monoxide to meso- and (+/-)-diepoxybutane by cDKA-expressed human cytochrome P450s and by mouse, rat, and human liver microsomes: evidence for preferential hydration of meso-diepoxybutane in rat and human liver microsomes. Arch Biochem Biophys 1997; 337:176-84.
12. Cochrane JE, Skopek TR. Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, l,2,3.4- diepoxybutane and 3,4-epoxy- 1,2-hutanediol in cultured human lymphoblasts. Carcinogenesis 1994;15:713-7.
13. Park S, Tretyakova N. Structural characterization of the major DKA-DKA cross4ink of 1,2,3,4-diepoxybutane, Chem Res Toxicol 2004;17:129-36.
14. Zhang XY, Elfarra AA. Reaction of 1,2,3,4-diepoxyhu- tane with 2'-deoxyguanosine: initial products and their stabilities and decomposition patterns under physiological conditions. Chem Res Toxicol 2005;18:1316-23.
15. Himmelstein MW, Acquavella JF, Recio L, Medinsky MA, Bond JA. Toxicology and epidemiology of 1,3- butadiene. Crit Rev Toxicol 1997;27:1-108.
16. Tretyakova NY, Sangaiah R, Yen TY, Swenberg JA. Synthesis, characterization, and in vitro quantitation of N-7-guanine adducts of diepoxybutane. Chem Res Toxicol 1997;10:779-85.
17. Park S, Hodge J, Anderson C, Tretyakova NY. Guanine-adenine cross-linking by 1,2,3,4-diepoxybutane: potential basis for biological activity. Chem Res Toxicol 2004;17:1638-51.
18. Goggin M, Anderson C, Park S, Swenberg j, Walker V, Tretyakova N. Quantitative high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry analysis of the adenine-guanine crosslinks of 1,2,3,4-diepoxybutane in tissues of butadiene- exposed B6C3F1 mice. Chem Res Toxicol 2008;21: 1163-70.
19. Owen PE, Glaister JR, Gaunt IE, Pullinger DH. Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity /carcinogenicity study in rate. Am Ind Hyg Assoc j 1987;48:407-13.
20. Jelitto B, Vangala RR, Laib RJ. Species differences in DNA damage by butadiene: role of diepoxybutane. Arch Toxicol Suppl 1989;13:246-9.
21. Henderson R1-, Barr EB, Belinsky SA, Benson JM, Hahn EE, Menache MG. 1,3-butadiene: cancer, mutations, and adducts. Part I: Carcinogenicity of 1,2,3,4-diepoxybutane. Res Rep Health Eff Inst 2000;ll-43.
22. Henderson RE, Thorn ton-Manning JR, Bechtold WE, Dahl AR. Metabolism of 1,3-butadiene: species differences. Toxicology 1996;113:17-22.
23. Thornton-Manning JR, Dahl AR, Bechtold WE, Griffith WC, Jr., Henderson RF. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Carcinogenesis 1995;16:1723-31.
24. Boysen G, Georgieva NI, Upton PB, et al. Analysis of diepoxide- specific cyclic N-terminal globin adducts in mice and rats after inhalation exposure to 1,3-butadiene. Cancer Res 2004;64:8517-20.
25. Filser JG, Hutzler C, Meischner V, Veereshwarayya V, Csanady GA. Metabolism of 1,3-butadiene to toxicolog- ically relevant metabolites in single-exposed mice and rats,' Chem Biol Interact 2007;166:93-103.
26. Kligerman AD, DeMarini DM, Doerr CL, Hanley NM, Milholland VS, Tennant. AH. Comparison of cytogenetic effects of 3,4-epoxy-l-butene and 1,2:3, 4-die poxy but an e in mouse, rat and human lymphocytes following in vitro GO exposures. Mutat Res 1999;439:13-23.
27. Kligerman AD, Hu Y. Some insights into the mode of action of butadiene by examining the genotoxicity of its metabolites. Chem Biol Interact 2006. Epub ahead of print 2006 Apr 18.
28. Koc H, Tretyakova NY, Walker VE, Henderson RF, Swenherg JA. Molecular dosimetry of N-7 guanine adduct formation in mice and rate exposed to 1,3- butadiene. Chem Res Toxicol 1999;12:566-74.
29. SwenbergJA, Boysen G, Georgieva M, Bird MG, Lewis Rj, Future directions in butadiene risk assessment and the role of cross-species Internal dosimetry. Chem Biol Interact 2007;166:78-83.
30. Goggin M, Loeber R, Park S, Walker V, Wickliffe J, Tretyakova N. HPLC-ESI+-MS/MS analysis of N7-gua- nine-N7-guanine DNA cross-links in tissues of mice exposed to 1,3-butadiene. Chem Res Toxicol 2007;20: 839-47.
31. Park S, Anderson C, Loeber R, Seetharaman M, Jones R, Tretyakova N. Interstrand and intrastrand DNA-DNA eross4inking by 1,23.4-diepoxybutane: role of stereochemistry. J Am Chem Soc 2005;127:14355-65.
32. Singer B, Grunberger D. Molecular biology of mutagens and carcinogens. New York and London: Plenum Press; 1983.
33. Tretyakova NY, Lin YP, Upton PB, Sangaiah Rf Swenberg JA Macromolecular adducts of butadiene. Toxicology 1996;113:70-6.
34. Koivisto P, Adler ID, Pacchierotti F, Peltonen K. DNA adducts in mouse testis and lung after inhalation exposure to 1,3-butadiene. Mutat Res 1998; 397:3-10.
35. Oesch-Bartlomovvicz B, Padma PR, Becker R, et al. Differential modulation of CYP2E1 activity by eAMP- dependent protein kinase upon Serl29 replacement, Exp Cell Res 1998;242:294-302.
36. Boysen G, Scarlett CO, Temple B, et al. Identification of covalent modifications in P450 2E1 by l,2-epoxy-3- butene in vitro. Chem Biol interact 2007;166:170-5.
37. Boysen G, Georgieva NI, Upton PB, Walker VE, Swenberg JA. N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides. Chem Biol Interact 2007;166:84-92.
38. Swenberg JA, Eryar-Tita E, Jeong YC, et al. Biomarkers in toxicology and risk assessment: informing critical dose-response relationships. Chem Res Toxicol 2008;21:253-65.
39. Thornton-Manning JR, Dahl AR, Bechtold WE, Henderson RE. Gender and species differences in the metabolism of 1,3-hutadlene to butadiene monoep- oxide and butadiene diepoxide in rodents following low-level inhalation exposures. Toxicology 1996;113: 322-5.
40. Hayes RB, Zhang L, Yin S, et al. Genotoxic markers among butadiene polymer workers in China. Carcinogenesis 2000;21:55-62.
41. Albertini RJ, Sram RJ, Vacek PM, et al. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons. Chem Biol Interact 2007;166:63-77.
42. Millard JT, White MM. Diepoxybutane cross-links DMA at 5'-GNC sequences. Biochemistry 1993;32:2120-4.
43. Millard JT, Wilkes EE. Diepoxybutane and diepoxy- octane interstrand cross-linking of the 5S DNA nucleo- somal core particle. Biochemistry 2001;40:10677-85.
44. Millard JT, Hanly TC, Murphy K, Tretyakova N, The 5'-GNC site for DNA interstrand cross-linking is conserved for diepoxybutane stereoisomers. Chem Res Toxicol 2006;19:16-9.
45. Lawley PD, Brookes P. Interstrand cross-linking of DNA by difunctional alkylating agents. J Mol Biol 1967; 25:143-60.